Institute of Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Germany.
Atherosclerosis. 2011 Dec;219(2):630-6. doi: 10.1016/j.atherosclerosis.2011.08.050. Epub 2011 Sep 6.
Given the multimodal medical and interventional treatment options in coronary artery disease (CAD), the current value of intensified lifestyle modification remains unclear. No randomized studies have so far assessed the impact of lifestyle modification on coronary artery calcium (CAC). We examined the long-term effects of a one-year comprehensive lifestyle modification on risk factors and CAC by means of a randomized clinical trial.
96 participants (age range 35-75 years, 22 women) of the SAFE-LIFE randomized trial in patients with established CAD completed 3-year follow-up. The active treatment was a one-year lifestyle modification and stress reduction intervention (LG), while the control group received written advice only (AG). CAC (derived from electron beam tomography), blood lipids, heart rate, blood pressure, anginal symptoms and quality-of-life were assessed on entry and at 3-year follow-up.
Lifestyle modification had no impact on change of CAC after three years (median progression factor [25th,75th percentile] 1.46 [1.16,2.19] in LG and 1.41 [1.20,1.79] in AG; p=0.68), but led to reductions of blood pressure, heart rate and to dose-reductions in anti-ischemic medications as compared to AG. Multiple regression analysis indicated that in the pooled study population increase of CAC was related to psychosocial factors and heart rate.
In the presence of modern treatments, complementary prescription of comprehensive lifestyle modification has no impact on CAC progression but sustainable benefit for blood pressure, heart rate and the need of anti-ischemic medication is demonstrated. A possible influence of stress reduction measures on CAC progression should be further evaluated.
鉴于冠心病(CAD)有多种医学和介入治疗选择,强化生活方式改变的当前价值尚不清楚。迄今为止,尚无随机研究评估生活方式改变对冠状动脉钙(CAC)的影响。我们通过一项随机临床试验,检查了为期一年的综合生活方式改变对危险因素和 CAC 的长期影响。
在已确诊 CAD 的患者中进行的 SAFE-LIFE 随机试验中,96 名参与者(年龄 35-75 岁,22 名女性)完成了 3 年随访。积极治疗是为期一年的生活方式改变和减轻压力干预(LG),而对照组仅接受书面建议(AG)。在入组时和 3 年随访时评估 CAC(源自电子束断层扫描)、血脂、心率、血压、心绞痛症状和生活质量。
生活方式改变在三年后对 CAC 的变化没有影响(中位数进展因子[25%,75%分位数]LG 为 1.46 [1.16,2.19],AG 为 1.41 [1.20,1.79];p=0.68),但与 AG 相比,血压、心率降低,抗缺血药物剂量减少。多元回归分析表明,在 pooled 研究人群中,CAC 的增加与心理社会因素和心率有关。
在存在现代治疗方法的情况下,补充综合生活方式改变的处方对 CAC 进展没有影响,但可持续降低血压、心率和抗缺血药物的需求。应进一步评估减压措施对 CAC 进展的可能影响。